Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Immunol. 2018 Nov 30;202(1):105–118. doi: 10.4049/jimmunol.1800598

Figure 2: CCL2 Selectively Inhibits HIV- and TLR3-Induced IFN-α.

Figure 2:

Following treatment/infection with vehicle, HIV, or pIC, MDM from nine donors were treated with CCL2, CCL7, CCL8, CCL5 or vehicle and qRT-PCR performed to quantify (A) IFN-α, (B) IFN-β, (C) TRAIL, or (D) MxA.